Harnessing the power of human genetics to transform the lives of patients

We are committed to developing breakthrough precision medicines for common diseases with large unmet medical needs.

Dramatic advances in human genetics, variant functionalization, therapeutic discovery and development methods, coupled with traditional drug development and area expertise enable us to decode the genetic drivers for a wide range of serious diseases.

Our Commitment to Kidney Disease

Maze Therapeutics is developing medicines designed to imitate the effects of rare, naturally occurring, protective genetic variants and help protect the kidneys from disease. Our first such precision medicine program is directed against APOL1 kidney disease. Learn more about our next programs focused on targeted treatements for chronic kidney disease here.